Stay updated on Ziftomenib in AML Clinical Trial
Sign up to get notified when there's something new on the Ziftomenib in AML Clinical Trial page.

Latest updates to the Ziftomenib in AML Clinical Trial page
- Check5 days agoChange DetectedThe record history shows an additional later update (2026-04-21) with changes limited to Study Status and Contacts/Locations. Another older entry is reflected as removed (2025-11-10), but no substantive study details are indicated as changing.SummaryDifference0.2%

- Check12 days agoChange DetectedThe page footer now displays Revision: v3.5.2, replacing v3.5.0.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check41 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed from the page history.SummaryDifference0.0%

- Check48 days agoChange DetectedRevision: v3.4.3 has been added as the latest update, replacing the previous v3.4.2 entry.SummaryDifference0.0%

- Check76 days agoChange DetectedAdded Revision: v3.4.2 and removed the funding/operating-status notice as well as Revision: v3.4.1 from the page history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check83 days agoChange DetectedAdded a government funding notice banner noting potential data delays and that the NIH Clinical Center is open. Updated the page revision to v3.4.1 (replacing v3.4.0).SummaryDifference0.4%

Stay in the know with updates to Ziftomenib in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ziftomenib in AML Clinical Trial page.